Price movement over the last 24 hours
Align Technology, Inc. vs First Trust NASDAQ Clean Edge Green Energy Idx Fd — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while First Trust NASDAQ Clean Edge Green Energy Idx Fd trades at $54.5. Which is the better fit depends on your goals.
| ALGN | QCLN | |
|---|---|---|
Market Cap | $12.86B | — |
Sector | Health | Sector/Thematic |
52-Week High | $207.19 | $68.47 |
52-Week Low | $124.88 | $34.31 |
Enterprise Value | $11.92B | — |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
QCLN trades at $55.7, down 1.5% amid a bearish technical setup with moving averages and ADX signaling selling pressure. The clean energy ETF faces mixed sentiment as policy uncertainty under the Trump administration threatens $121 billion in renewable investments, while global demand for low-emission power grows. Key support sits at $55 with resistance at $57.
Outlook remains cautious due to regulatory headwinds and supply chain costs, but long-term exposure to energy transition themes offers potential. Risks include U.S.-China trade tensions and volatile commodity prices affecting solar and wind projects.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →QCLN invests in U.S.-listed companies engaged in clean energy technologies. It focuses on solar power, wind, electric vehicles, and energy storage, with major holdings in firms like Tesla, ON Semiconductor, and Rivian.
Read more on QCLN →